peter attia tirzepatide 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - The Drive Dr. Peter Attia on The

Higher concentrations have not demonstrated proportionally greater effects in available research

Benjamin Ferrer Noom upgrades GLP-1 weight management app features as digital therapeutics gain US market traction Benjamin Ferrer Weight management app Noom has revealed a major update to its GLP-1 Companion service to accompany and optimize popular GLP-1 drug therapies, which can cause temporary and long-term side effects like critical nutritional gaps and muscle loss

That said, whether Ozempic is a long-term drug can depend on the reason youre taking the medication

( Pseudomonas infections in vitro

Experiment to find what minimizes your side effects